Patents by Inventor Clara Hwang

Clara Hwang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING A PATIENT AT RISK FOR DEVELOPING AN NSAID-ASSOCIATED ULCER
    Publication number: 20160166558
    Abstract: The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof to said at risk patient and thereby decreasing the patient's risk of developing an ulcer.
    Type: Application
    Filed: February 23, 2016
    Publication date: June 16, 2016
    Applicants: POZEN INC., HORIZON PHARMA USA, INC.
    Inventors: Brian AULT, Clara HWANG, Everardus Orlemans, John R. PLACHETKA, Mark SOSTEK
  • METHOD FOR TREATING A PATIENT AT RISK FOR DEVELOPING AN NSAID-ASSOCIATED ULCER
    Publication number: 20150202193
    Abstract: The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof to said at risk patient and thereby decreasing the patient's risk of developing an ulcer.
    Type: Application
    Filed: January 9, 2015
    Publication date: July 23, 2015
    Applicants: POZEN INC., HORIZON PHARMA USA, INC.
    Inventors: Brian AULT, Clara HWANG, Everardus Orlemans, John R. PLACHETKA, Mark SOSTEK
  • Method for treating a patient at risk for developing an NSAID-associated ulcer
    Patent number: 8945621
    Abstract: The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof to said at risk patient and thereby decreasing the patient's risk of developing an ulcer.
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: February 3, 2015
    Assignees: Pozen Inc., Horizon Pharma USA, Inc.
    Inventors: Brian Ault, Clara Hwang, Everardus Orlemans, John R Plachetka, Mark Sostek
  • Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer
    Publication number: 20100330179
    Abstract: The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof to said at risk patient and thereby decreasing the patient's risk of developing an ulcer.
    Type: Application
    Filed: June 24, 2010
    Publication date: December 30, 2010
    Applicants: ASTRAZENECA AB, POZEN INC.
    Inventors: Brian Ault, Clara Hwang, Everardus Orlemans, John R. Plachetka, Mark Sostek